Environmental risk factors for breast cancer among African-American women

Cancer

Volumn 97, Issue 1 SUPPL., 2003, Pages 289-310

  Wolff, Mary S ^a   Britton, Julie A ^a   Wilson, Valerie P ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

African American; Breast cancer; Environment gene; Environmental; Gene environment; Occupational; Risk; Susceptibility; Vulnerability

Indexed keywords

1,2 DIBROMOETHANE; 1,3 BUTADIENE; 3 METHYLCHOLANTHRENE; AROMATIC AMINE; BENZENE DERIVATIVE; CARBON TETRACHLORIDE; CARCINOGEN; DICHLOROMETHANE; DIETHYLSTILBESTROL; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; METHYLNITROSOUREA; MUTAGENIC AGENT; VINYL CHLORIDE;

BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENIC ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; ENVIRONMENTAL CHANGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ESTROGEN METABOLISM; ETHNIC GROUP; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OCCUPATIONAL EXPOSURE; ONCOGENE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; TUMOR SUPPRESSOR GENE;

EID: 0037217001     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11023     Document Type: Conference Paper

References (251)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
2. Dong C, Hemminki K. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer. 2001;92:144-150.
3. Anonymous. SEER Cancer Statistics Review, 1973-1997. Bethesda: National Cancer Institute, 2000.
4. Trock BJ. Breast cancer in African American women: Epidemiology and tumor biology. Breast Cancer Res Treat. 1996;40:11-24.
5. Brinton LA, Benichou J, Gammon MD, Brogan DR, Coates R, Schoenberg JB. Ethnicity and variation in breast cancer incidence. Int J Cancer. 1997;73:349-355.
6. Huff J. Animal and human carcinogens. Environ Health Perspect. 1999;107:A341-A342.
7. Huff J. Breast cancer risks from environmental chemicals. Eur J Oncol. 2000;5:127-132.
8. Dunnick JK, Elwell MR, Huff J, Barrett JC. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay. Carcinogenesis. 1995; 16:173-179.
9. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993;101:378-384.
10. Rudel RA, Brody JG, Spengler JD, et al. Identification of selected hormonally active agents and animal mammary carcinogens in commercial and residential air and dust samples. J Air Waste Manag Assoc. 2001;51:499-513.
11. Aschengrau A, Coogan PF, Quinn M, Cashins LJ. Occupational exposure to estrogenic chemicals and the occurrence of breast cancer: An exploratory analysis. Am J Ind Med. 1998;34:6-14.
12. Robison AK, Sirbasku DA, Stancel GM. DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett. 1985; 27:109-113.
13. Nesaretnam K, Hales E, Sohail M, Krausz T, Darbre P. 3,3',4,4'-tetrachlorobiphenyl (TCB) can enhance DMBA-induced mammary carcinogenesis in the rat. Eur J Cancer. 1998;34:389-393.
14. Vineis P, D'Amore F. The role of occupational exposure and immunodeficiency in B-cell malignancies. Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy. Epidemiology. 1992;3:266-270.
15. Goldberg MS, Labreche F. Occupational risk factors for female breast cancer: A review. Occup Environ Med. 1996; 53:145-156.
16. Band PR, Le ND, Fang R, Threlfall WJ, Gallagher RP. Identification of occupational cancer risks in British Columbia. Part II: A population-based case-control study of 1516 prostatic cancer cases. J Occup Environ Med. 1999;41:233-247.
17. Petralia SA, Vena JE, Freudenheim JL, et al. Risk of premenopausal breast cancer and patterns of established breast cancer risk factors among teachers and nurses. Am J Ind Med. 1999;35:137-141.
18. Rubin CH, Burnett CA, Halperin WE, Seligman PJ. Occupation as a risk identifier for breast cancer. Am J Public Health. 1993;83:1311-1315.
19. Petralia SA, Vena JE, Freudenheim JL, et al. Breast cancer risk and lifetime occupational history: Employment in professional and managerial occupations. Occup Environ Med. 1998;55:43-48.
20. Reynolds P, Elkin EP, Layefsky ME, Lee GM. Cancer in California school employees, 1988-1992. Am J Ind Med. 1999;36:271-278.
21. Cantor KP, Stewart PA, Brinton LA, Dosemeci M. Occupational exposures and female breast cancer mortality in the United States. J Occup Environ Med. 1995;37:336-348.
22. Hall NE, Rosenman KD. Cancer by industry: Analysis of a population-based cancer registry with an emphasis on blue-collar workers. Am J Ind Med. 1991;19:145-159.
23. Lamba AB, Ward MH, Weeks JL, Dosemeci M. Cancer mortality patterns among hairdressers and barbers in 24 US states, 1984 to 1995. J Occup Environ Med. 2001;43:250-258.
24. Petralia SA, Vena JE, Freudenheim JL, et al. Risk of premenopausal breast cancer in association with occupational exposure to polycyclic aromatic hydrocarbons and benzene. Scand J Work Environ Health. 1999;25:215-221.
25. Morton WE. Major differences in breast cancer risks among occupations. J Occup Environ Med. 1995;37:328-335.
26. Habel LA, Stanford JL, Vaughan TL, et al. Occupation and breast cancer risk in middle-aged women. J Occup Environ Med. 1995;37:349-356.
27. Blair A, Dosemeci M, Heineman EF. Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med. 1993;23:729-742.
28. Duell EJ, Millikan RC, Savitz DA, et al. A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology. 2000;11:523-531.
29. Rosenberg L, Palmer JR, Rao RS, Adams-Campbell LL. Risk factors for coronary heart disease in African American women. Am J Epidemiol. 1999;150:904-909.
30. Tokunaga M, Land CE, Tokuoka S, Nishimori I, Soda M, Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994;138: 209-223.
31. Sadetzki S, Chetrit A, Modan B. A 45-year follow-up of people treated by X-ray for a benign condition (tinea capitis) during childhood. Proc Am Assoc Cancer Res. 2001;42: 408-409.
32. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst. 2001; 93:618-629.
33. Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control. 2000;11:271-278.
34. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: A population-based study (Iceland). Cancer Causes Control. 2001;12:95-101.
35. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. Br Med J. 1995;311:649-652.
36. Boice JD Jr., Blettner M, Auvinen A. Epidemiologic studies of pilots and aircrew. Health Phys. 2000;79:576-584.
37. Demers PA, Thomas DB, Rosenblatt KA, et al. Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol. 1991;134:340-347.
38. Tynes T, Andersen A. Electromagnetic fields and male breast cancer. Lancet. 1990;336:1596.
39. Matanoski GM, Breysse PN, Elliott EA. Electromagnetic field exposure and male breast cancer. Lancet. 1991;337: 737.
40. Floderus B, Tornqvist S, Stenlund C. Incidence of selected cancers in Swedish railway workers, 1961-79. Cancer Causes Control. 1994;5:189-194.
41. Loomis DP, Savitz DA, Ananth CV. Breast cancer mortality among female electrical workers in the United States. J Natl Cancer Inst. 1994;86:921-925.
42. Coogan PF, Clapp RW, Newcomb PA, et al. Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology. 1996;7:459-464.
43. Pollan M, Gustavsson P. High-risk occupations for breast cancer in the Swedish female working population. Am J Public Health. 1999;89:875-881.
44. Caplan LS, Schoenfeld ER, O'Leary ES, Leske MC. Breast cancer and electromagnetic fields - A review. Ann Epidemiol. 2000;10:31-44.
45. McDowall ME. Mortality of persons resident in the vicinity of electricity transmission facilities. Br J Cancer. 1986;53: 271-279.
46. Wertheimer N, Leeper E. Adult cancer related to electrical wires near the home. Int J Epidemiol. 1982;11:345-355.
47. Wertheimer N, Leeper E. Magnetic field exposure related to cancer subtypes. Ann N Y Acad Sci. 1987;502:43-54.
48. Schreiber GH, Swaen GM, Meijers JM, Slangen JJ, Sturmans F. Cancer mortality and residence near electricity transmission equipment: A retrospective cohort study. Int J Epidemiol. 1993;22:9-15.
49. Verkasalo PK, Pukkala E, Kaprio J, Heikkila KV, Koskenvuo M. Magnetic fields of high voltage power lines and risk of cancer in Finnish adults: Nationwide cohort study. Br Med J. 1996;313:1047-1051.
50. Li CY, Theriault G, Lin RS. Residential exposure to 60-Hertz magnetic fields and adult cancers in Taiwan. Epidemiology. 1997;8:25-30.
51. Feychting M, Forssen U, Rutqvist LE, Ahlbom A. Magnetic fields and breast cancer in Swedish adults residing near high-voltage power lines. Epidemiology. 1998;9:392-397.
52. Coogan PF, Aschengrau A. Exposure to power frequency magnetic fields and risk of breast cancer in the Upper Cape Cod Cancer Incidence Study. Arch Environ Health. 1998; 53:359-367.
53. Gammon MD, Schoenberg JB, Britton JA, et al. Electric blanket use and breast cancer risk among younger women. Am J Epidemiol. 1998;148:556-563.
54. Vena JE, Graham S, Hellmann R, Swanson M, Brasure J. Use of electric blankets and risk of postmenopausal breast cancer. Am J Epidemiol. 1991;134:180-185.
55. Vena JE, Freudenheim JL, Marshall JR, Laughlin R, Swanson M, Graham S. Risk of premenopausal breast cancer and use of electric blankets. Am J Epidemiol. 1994;140:974-979.
56. Wertheimer N, Leeper E. Re: "Risk of premenopausal breast cancer and use of electric blankets" and "Use of electric blankets and risk of postmenopausal breast cancer." Am J Epidemiol. 1996;142:1344-1345.
57. Vena JE, Freudenheim JL, Marshall JR, Swanson M, Graham S. Re: "Risk of premenopausal breast cancer and use of electric blankets" and "Use of electric blankets and risk of postmenopausal breast cancer." Am J Epidemiol. 1995; 142:1345.
58. Palmer JR, Rosenberg L. Cigarette smoking and the risk of breast cancer. Epidemiol Rev. 1993;15:145-156.
59. Ranstam J, Olsson H. Alcohol, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev. 1995;19:487-493.
60. Baron JA, Newcomb PA, Longnecker MP, et al. Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev. 1996;5:399-403.
61. Bennicke K, Conrad C, Sabroe S, Sorensen HT. Cigarette smoking and breast cancer. Br Med J. 1995;310:1431-1433.
62. Mayberry RM. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol. 1994;4:205-213.
63. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol. 1984;119:9-22.
64. Lash TL, Aschengrau A. Active and passive cigarette smoking and the occurrence of breast cancer. Am J Epidemiol. 1999;149:5-12.
65. Russo IH, Russo J. Mammary gland neoplasia in long-term rodent studies. Environ Health Perspect. 1996;104:938-967.
66. El Bayoumy K. Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol. 1992;5:585-950.
67. Moore CJ, Gould MN. Differences in mediated mutagenesis and polycyclic aromatic hydrocarbon metabolism in mammary cells from pregnant and virgin rats. Carcinogenesis. 1984;5:103-108.
68. Innes KE, Byers TE. Smoking during pregnancy and breast cancer risk in very young women (United States). Cancer Causes Control. 2001;12:179-185.
69. Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7:371-378.
70. Morabia A, Bernstein M, Heritier S, Khatchatrian N. Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol. 1996;143:918-928.
71. Wells AJ. Re: "Breast cancer, cigarette smoking, and passive smoking." Am J Epidemiol. 1998;147:991-992.
72. Morabia A, Bernstein M, Heritier S. Re: "Smoking and breast cancer: Reconciling the epidemiologic evidence by accounting for passive smoking and/or genetic susceptibility." Am J Epidemiol. 1998;147:992-993.
73. Whidden P. Re: "Relation of breast cancer with passive and active exposure to tobacco smoke." Am J Epidemiol. 1998; 147:994.
74. Zheng W, Gustafson DR, Sinha R, et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998;90:1724-1729.
75. De Stefani E, Ronco A, Mendilaharsu M, Guidobono M, Deneo-Pellegrini H. Meat intake, heterocyclic amines, and risk of breast cancer: A case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev. 1997;6:573-581.
76. Gertig DM, Hankinson SE, Hough H, et al. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer. 1999;80:13-17.
77. Ambrosone CB, Freudenheim JL, Sinha R, et al. Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer. 1998;75:825-830.
78. Cavalieri E, Rogan E, Sinha D. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland. J Cancer Res Clin Oncol. 1988;114:3-9.
79. Trombino AF, Near RI, Matulka RA, et al. Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res Treat. 2000;63: 117-131.
80. Perera FP, Estabrook A, Hewer A, et al. Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev. 1995;4:233-238.
81. Santella RM, Gammon MD, Zhang YJ, et al. Immunohistochemical analysis of polycyclic aromatic hydrocarbon-DNA adducts in breast tumor tissue. Cancer Lett. 2000;154: 143-149.
82. Li D, Zhang W, Sahin AA, Hittelman WN. DNA adducts in normal tissue adjacent to breast cancer: A review. Cancer Detect Prev. 1999;23:454-462.
83. Rundle A, Tang D, Hibshoosh H, et al. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis. 2000;21:1281-1289.
84. Blaszyk H, Vaughn CB, Hartmann A, et al. Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer. Lancet. 1994;343:1195-1197.
85. Chen VW, Wu XC, Andrews PA, Correa CN, Lucas HF. Highlights of cancer incidence in Louisiana, 1988-1992. J La State Med Soc. 1997;149:119-124.
86. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst. 1994;86:705-712.
87. Holcomb M, Safe S. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 1994;82:43-47.
88. Kociba RJ, Keyes DG, Beyer JE, et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978;46:279-303.
89. Scribner JD, Mottet NK. DDT acceleration of mammary gland tumors induced in the male Sprague-Dawley rat by 2-acetamidophenanthrene. Carcinogenesis. 1981;2:1235-1239.
90. Moysich KB, Ambrosone CB, Vena JE, et al. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7:181-188.
91. Millikan R, DeVoto E, Duell EJ, et al. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev. 2000;9:1233-1240.
92. Hoyer AP, Jorgensen T, Brock JW, Grandjean P. Organochlorine exposure and breast cancer survival. J Clin Epidemiol. 2000;53:323-330.
93. Davies JE, Edmundson WF, Maceo A, Barquet A, Cassady J. An epidemiologic application of the study of DDE levels in whole blood. Am J Public Health Nations Health. 1969;59: 435-441.
94. Kutz FW, Yobs AR, Strassman SC. Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med. 1977;19pcb:619-622.
95. Finklea J, Priester LE, Creason JP, Hauser T, Hinners T, Hammer DI. Polychlorinated biphenyl residues in human plasma expose a major urban pollution problem. Am J Public Health. 1972;62:645-651.
96. Zheng T, Holford TR, Mayne ST, et al. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol. 1999;150:453-458.
97. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women. J Natl Cancer Inst. 1994;86:589-599.
98. Wolff MS, Berkowitz GS, Brower S, et al. Organochlorine exposures and breast cancer risk in New York City women. Environ Res. 2000;84:151-161.
99. Laden F, Hankinson SE, Wolff MS, et al. Plasma organochlorine levels and the risk of breast cancer: An extended follow-up in the Nurses' Health Study. Int J Cancer. 2001; 91:568-574.
100. Zheng T, Holford TR, Mayne ST, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev. 2000;9:167-174.
101. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev. 2000;9:161-166.
102. Gammon MD, Wolff MS, Neugent AI, et al. Environmental toxins and breast cancer on Long Island. II. Organochloride compound levels in blood. Cancer Epidemiol Biomarkers Prev. 2002;8:686-697.
103. Laden F, Collman G, Iwamoto K, et al. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: Combined analysis of five U.S. studies. J Natl Cancer Inst. 2001;93:768-775.
104. Stellman SD, Djordjevic MV, Britton JA, et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev. 2000; 9:1241-1249.
105. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB. Organochlorine exposure and risk of breast cancer. Lancet. 1998;352:1816-1820.
106. Aronson KJ, Miller AB, Woolcott CG, et al. Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:55-63.
107. Hoyer AP, Jorgensen T, Grandjean P, Hartvig HB. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control. 2000;11:177-184.
108. Dorgan JF, Brock JW, Rothman N, et al. Serum organochlorine pesticides and PCBs and breast cancer risk: Results from a prospective analysis (USA). Cancer Causes Control. 1999;10:1-11.
109. Romieu I, Hernandez-Avila M, Lazcano-Ponce E, Weber JP, Dewailly E. Breast cancer, lactation history, and serum organochlorines. Am J Epidemiol. 2000;152:363-370.
110. Moysich KB, Shields PG, Freudenheim JL, et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:41-44.
111. Blanck HM, Marcus M, Tolbert PE, et al. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology. 2000;11:641-647.
112. Gladen BC, Ragan NB, Rogan WJ. Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr. 2000;136:490-496.
113. Gray GE, Henderson BE, Pike MC. Changing ratio of breast cancer incidence rates with age of black females compared with white females in the United States. J Natl Cancer Inst. 1980;64:461-463.
114. Gray GE, Pike MC, Hirayama T, et al. Diet and hormone profiles in teenage girls in four countries at different risk for breast cancer. Prev Med. 1982;11:108-113.
115. Richards RJ, Svec F, Bao W, Srinivasan SR, Berenson GS. Steroid hormones during puberty: Racial (black-white) differences in androstenedione and estradiol - The Bogalusa Heart Study. J Clin Endocrinol Metab 1992;75:624-631.
116. Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC. Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol. 1994;139:1035-1046.
117. Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental risk factors: Epidemiological and experimental findings. Annu Rev Pharmacol Toxicol. 1996;36: 573-596.
118. Dean AG, Imrey HH, Dusich K, Hall WN. Adjusting morbidity ratios in two communities using risk factor prevalence in cases. Am J Epidemiol. 1988;127:654-662.
119. Marcus PM, Savitz DA, Millikan RC, Morgenstern H. Female breast cancer and trihalomethane levels in drinking water in North Carolina. Epidemiology. 1998;9:156-160.
120. Weyer PJ, Cerhan JR, Kross BC, et al. Municipal drinking water nitrate level and cancer risk in older women: The Iowa Women's Health Study. Epidemiology. 2001;12:327-338.
121. Kettles MK, Browning SR, Prince TS, Horstman SW. Triazine herbicide exposure and breast cancer incidence: An ecologic study of Kentucky counties. Environ Health Perspect. 1997;105:1222-1227.
122. Lewis-Michl EL, Melius JM, Kallenbach LR, et al. Breast cancer risk and residence near industry or traffic in Nassau and Suffolk Counties, Long Island, New York. Arch Environ Health. 1996;51:255-265.
123. Aschengrau A, Paulu C, Ozonoff D. Tetrachloroethylene-contaminated drinking water and the risk of breast cancer. Environ Health Perspect. 1998;106(Suppl 4):947-953.
124. Russo J, Hu YF, Yang X, Russo IH. Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr. 2000;27:17-37.
125. Ramamoorthy K, Wang F, Chen IC, et al. Potency of combined estrogenic pesticides. Science. 1997;275:405-406.
126. Payne J, Rajapakse N, Wilkins M, Kortenkamp A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect. 2000;108:983-987.
127. Rajapakse N, Ong D, Kortenkamp A. Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens. Toxicol Sci. 2001;60:296-304.
128. Daniel V, Huber W, Bauer K, Suesal C, Conradt C, Opelz G. Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies. Environ Health Perspect. 2001;109:173-178.
129. Nordstrom M, Hardell L, Lindstrom G, Wingfors H, Hardell K, Linde A. Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia. Environ Health Perspect. 2000;108: 441-445.
130. Rothman N, Cantor KP, Blair A, et al. A nested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet. 1997;350:240-244.
131. Laden F, Hunter D, Cantor K, et al. Non-Hodgkin's lymphoma and plasma levels of DDE and PCBs. Epidemiology. 2000;SER abstracts:S23-S23.
132. Yasui Y, Potter JD, Stanford JL, et al. Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001;10:9-16.
133. Bonnet M, Guinebretiere JM, Kremmer E, et al. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999;91:1376-1381.
134. Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses. 1997;48:491-497.
135. Wolff MS, Anderson HA. Correspondence re: Schildkraut JM et al., Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev. 1999;8:179-183 [letter]. Cancer Epidemiol Biomarkers Prev. 1999;8:951-952.
136. Wolff MS, Anderson HA. Correspondence re: Schildkraut JM et al., Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev. 1999;8:179-183 [letter]. Cancer Epidemiol Biomarkers Prev. 1999;8:951-952.
137. Schildkraut JM, Demark-Wahnefried W, DeVoto E, Hughes C, Laseter JL, Newman B. Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev. 1999;8:179-183.
138. Blanck HM, Marcus M, Hertzberg V, et al. Determinants of polybrominated biphenyl serum decay among women in the Michigan PBB cohort. Environ Health Perspect. 2000; 108:147-152.
139. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev. 1993;15:110-132.
140. Ballard-Barbash R, Swanson CA. Body weight: Estimation of risk for breast and endometrial cancer. Am J Clin Nutr. 1996;63(Suppl):437S-41S.
141. Cold S, Hansen S, Overvad K, Rose C. A woman's build and the risk of breast cancer. Eur J Cancer. 1998;34:1163-1174.
142. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152:514-527.
143. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev. 2001;10:15-32.
144. Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973;36:207-214.
145. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res Treat. 1990;16:205-214.
146. Camoriano JK, Loprinzi CL, Ingle JN, Themeau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8:1327-1334.
147. Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97:519-526, 529.
148. Koprowski C, Ross RK, Mack WJ, Henderson BE, Bernstein L. Diet, body size and menarche in a multiethnic cohort. Br J Cancer. 1999;79:1907-1911.
149. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annual Rev Publ Hlth. 1996;17:47-67.
150. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001;344:276-285.
151. Ambrosone CB, Marshall JR, Vena JE, et al. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk (New York, United States). Cancer Causes Control. 1995;6:407-415.
152. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst. 1999;91:547-556.
153. Freudenheim JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst. 1996;88:340-348.
154. Egan KM, Stampfer MJ, Rosner BA, et al. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev. 1998;7:359-364.
155. Schatzkin A, Palmer JR, Rosenberg L, et al. Risk factors for breast cancer in black women. J Natl Cancer Inst. 1987;78: 213-217.
156. McDougal A, Safe S. Induction of 16alpha-/2-hydroxyestrone metabolite ratios in MCF-7 cells by pesticides, carcinogens, and antiestrogens does not predict mammary carcinogens. Environ Health Perspect. 1998;106: 203-206.
157. Fowke JH, Longcope C, Hebert JR. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9: 773-779.
158. Whittemore AS. Risk of breast cancer in carriers of BRCA gene mutations. N Engl J Med. 1997;337:788-789.
159. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans. Cancer Res. 1998;58:65-70.
160. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis. 2000;21:427-433.
161. Hemminki K, Mutanen P. Genetic epidemiology of multistage carcinogenesis. Mutat Res. 2001;473:11-21.
162. Simon MS, Heilbrun LK, Stephens D, Lababidi S, Djuric Z. Recruitment for a pilot case control study of oxidative DNA damage and breast cancer risk. Am J Clin Oncol. 2000;23: 283-287.
163. Rojas M, Cascorbi I, Alexandrov K, et al. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis. 2000;21:35-41.
164. Flaws J, Lim C, Luo J, Bush T. Racial differences in tamoxifen metabolism. Ann Epidemiol. 2000;10:463-464.
165. Hong YC, Kim H, Im MW, Lee KH, Woo BH, Christiani DC. Maternal genetic effects on neonatal susceptibility to oxidative damage from environmental tobacco smoke. J Natl Cancer Inst. 2001;93:645-647.
166. Rundle A, Tang D, Zhou J, Cho S, Perera F. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev. 2000;9:1079-1085.
167. Romert L, Dock L, Jenssen D, Jernstrom B. Effects of glutathione transferase activity on benzo[a]pyrene 7,8-dihydrodiol metabolism and mutagenesis studied in a mammalian cell co-cultivation assay. Carcinogenesis. 1989;10:1701-1707.
168. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst. 1994;86:712-716.
169. Yu MC, Ross RK, Chan KK, et al. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev. 1995;4:861-864.
170. Goth-Goldstein R, Stampfer MR, Erdmann CA, Russell M. Interindividual variation in CYP1A1 expression in breast tissue and the role of genetic polymorphism. Carcinogenesis. 2000;21:2119-2122.
171. Alpert LC, Schecter RL, Berry DA, et al. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer. Clin Cancer Res. 1997;3: 661-667.
172. Peters WH, Roelofs HM, van Putten WL, Jansen JB, Klijn JG, Foekens JA. Response to adjuvant chemotherapy in primary breast cancer: No correlation with expression of glutathione S-transferases. Br J Cancer. 1993;68:86-92.
173. Coughlin SS, Piper M. Genetic polymorphisms and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8: 1023-1032.
174. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:843-854.
175. Tang YM, Green BL, Chen GF, et al. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics. 2000;10:761-766.
176. Bailey LR, Roodi N, Dupont WD, Parl FF. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer [published erratum appears in Cancer Res. 1999;59(6):1388]. Cancer Res. 1998; 58:5038-5041.
177. Zheng W, Xie DW, Jin F, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:147-150.
178. Taioli E, Bradlow HL, Garbers SV, et al. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev. 1999;23:232-237.
179. Huang CS, Shen CY, Chang KJ, Hsu SM, Chern HD. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer. 1999;80:1838-1843.
180. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: A multigenic study on cancer susceptibility. Cancer Res. 1999;59:4870-4875.
181. Fontana X, Peyrottes I, Rossi C, et al. Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mul gene in primary breast cancers: An update with an additional 114 cases. Mutat Res. 1998;403:45-53.
182. Krajinovic M, Ghadirian P, Richer C, et al. Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer. 2001;92:220-225.
183. Ishibe N, Hankinson SE, Colditz GA, et al. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res. 1998;58: 667-671.
184. Ambrosone CB, Freudenheim JL, Graham S, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 1995;55:3483-3485.
185. Zheng W, Deitz AC, Campbell DR, et al. N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:233-239.
186. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 1996;276:1494-1501.
187. Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA. Breast cancer and active and passive smoking: The role of the N-acetyltransferase 2 genotype. Am J Epidemiol. 2000; 152:226-232.
188. Hunter DJ, Hankinson SE, Hough H, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis. 1997;18:2127-2132.
189. Morabia A, Bernstein M, Heritier S. Re: Hunter DJ, Hankinson SE, Hough
190. Morabia A, Bernstein M, Heritier S. Re: Hunter DJ, Hankinson SE, Hough H, et al. A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis. 1997;18:2127-2132. Carcinogenesis. 1998;19:1705.
191. Deitz AC, Zheng W, Leff MA, et al. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:905-910.
192. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:89-94.
193. Delfino RJ, Sinha R, Smith C, et al. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis. 2000;21:607-615.
194. Huang CS, Chern HD, Shen CY, Hsu SM, Chang KJ. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in postmenopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer. 1999;82: 175-179.
195. Ambrosone CB, Freudenheim JL, Thompson PA, et al. Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 1999;59:602-606.
196. Pittman GS, Millikan RC, Bell DA. The SOD2 Val-9ala polymorphism and its association with breast cancer in a population-based case-control study. Proc Am Assoc Cancer Res. 2001;42:340-341.
197. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:567-573.
198. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis. 1993;14:1821-1824.
199. Garcia-Closas M, Kelsey KT, Hankinson SE, et al. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst. 1999;91:1960-1964.
200. Helzlsouer KJ, Selmin O, Huang HY, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst. 1998;90:512-518.
201. Maugard CM, Charrier J, Pitard A, et al. Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer. 2001;91:334-339.
202. Charrier J, Maugard CM, Le Mevel B, Bignon YJ. Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility. Br J Cancer. 1999;79:346-353.
203. Maugard CM, Charrier J, Bignon YJ. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. Chem Biol Interact. 1998;111-112:365-375.
204. Kelsey KT, Hankinson SE, Colditz GA, et al. Glutathione S-transferase class mu deletion polymorphism and breast cancer: Results from prevalent versus incident cases. Cancer Epidemiol Biomarkers Prev. 1997;6:511-515.
205. Lizard-Nacol S, Coudert B, Colosetti P, Riedinger JM, Fargeot P, Brunet-Lecomte P. Glutathione S-transferase M1 null genotype: Lack of association with tumour characteristics and survival in advanced breast cancer. Breast Cancer Res. 1999;1:81-87.
206. Sweeney C, McClure GY, Fares MY, et al. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. Cancer Res. 2000;60:5621-5624.
207. Gatti RA, Boder E, Vinters HV, Sparkes RS, Norman A, Lange K. Ataxia-telangiectasia: An interdisciplinary approach to pathogenesis. Medicine (Baltimore). 1991;70:99-117.
208. Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brcal at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J Biol Chem. 2001;276:17276-17280.
209. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:217-222.
210. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18:2309-2315.
211. Gammon MD, Hibshoosh H, Terry MB, et al. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol Biomarkers Prev. 1999;8:255-263.
212. Brentani MM, Neto MM, Salaorni S, Godoy A, Nagai MA. Pattern of TP53 mutation and polymorphism in primary breast carcinomas from black and white Brazilian patients. Proc Am Assoc Cancer Res. 2001;42:340.
213. Weston A, Wolff MS, Morabia A. True extended haplotypes of p53: Indicators of breast cancer risk [letter]. Cancer Genet Cytogenet. 1998;102:153-154.
214. Weston A, Godbold JH. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: A meta-analysis. Environ Health Perspect. 1997;105(Suppl 4):919-926.
215. Garrett PA, Hulka BS, Kim YL, Farber RA. HRAS protooncogene polymorphism and breast cancer. Cancer Epidemiol Biomarkers Prev. 1993;2:131-138.
216. Millikan R, DeVoto E, Newman B, Savitz D. Studying environmental influences and breast cancer risk: Suggestions for an integrated population-based approach. Breast Cancer Res Treat. 1995;35:79-89.
217. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: Conformationally restricted structural probes. Mol Pharmacol. 1988;33:120-126.
218. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-4263.
219. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p"-DDE is a potent androgen receptor antagonist. Nature. 1995;375:581-585.
220. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000;60:950-956.
221. Suchar LA, Chang RL, Thomas PE, Rosen RT, Lech J, Conney AH. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats. Endocrinology. 1996;137:663-676.
222. McWhorter WP, Schatzkin AG, Horm JW, Brown CC. Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer. 1989;63:982-987.
223. Krieger N, Quesenberry C Jr., Peng T, et al. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control. 1999;10:525-537.
224. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN. Geographic variation in mortality from breast cancer among white women in the United States. J Natl Cancer Inst. 1995;87:1846-1853.
225. Krieger N. Exposure, susceptibility, and breast cancer risk: A hypothesis regarding exogenous carcinogens, breast tissue development, and social gradients, including black/ white differences, in breast cancer incidence. Breast Cancer Res Treat. 1989;13:205-223.
226. Brown P. Race, class, and environmental health: A review and systematization of the literature. Environ Res. 1995;69: 15-30.
227. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol. 1994;49:389-404.
228. Sgoutas-Emch SA, Cacioppo JT, Uchino BN, et al. The effects of an acute psychological stressor on cardiovascular, endocrine, and cellular immune response: A prospective study of individuals high and low in heart rate reactivity. Psychophysiology. 1994;31:264-271.
229. Schedlowski M, Jacobs R, Alker J, et al. Psychophysiological, neuroendocrine and cellular immune reactions under psychological stress. Neuropsychobiology. 1993;28:87-90.
230. Trichopoulos D. Hypothesis: Does breast cancer originate in utero? Lancet. 1990;335:939-940.
231. Horn-Ross PL. Phytoestrogens, body composition, and breast cancer. Cancer Causes Control. 1995;6:567-573.
232. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control. 1999;10:561-573.
233. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: Prevention efforts must shift focus. Cancer Epidemiol Biomarkers Prev. 1995;4:567-571.
234. Bojkova B, Ahlers I, Kubatka P, Mocikova K, Mnichova M, Ahlersova E. Repeated administration of carcinogen in critical developmental periods increases susceptibility of female Wistar: Han rats to mammary carcinogenesis induction. Neoplasma. 2000;47:230-233.
235. Whitten PL, Patisaul HB. Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect. 2001;109(Suppl 1):5-20.
236. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505-512.
237. Moormeier J. Breast cancer in black women. Ann Intern Med. 1996;124:897-905.
238. Rothschild TC, Calhoon RE, Boylan ES. Effects of diethylstilbestrol exposure in utero on the genital tracts of female ACI rats. Exp Mol Pathol. 1988;48:59-76.
239. Chapin RE, Harris MW, Davis BJ, et al. The effects of perinatal/juvenile methoxychlor exposure on adult rat nervous, immune, and reproductive system function. Fundam Appl Toxicol. 1997;40:138-157.
240. Berkowitz GS, Marcus M. Occupational exposures and reproduction. In: Lee RV, Barron WM, Cotton DB, Couston DR. Current Obstetric Medicine. St. Louis, MO: Mosby-Year Book, 1993.
241. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124-133.
242. Gladen BC, Rogan WJ. DDE and shortened duration of lactation in a northern Mexican town. Am J Public Health. 1995;85:504-508.
243. Rogan WJ, Gladen BC, McKinney JD, et al. Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: Effects on growth, morbidity, and duration of lactation. Am J Public Health. 1987;77:1294-1297.
244. Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53:538-549.
245. Haynes MA, Smedley DB, eds. The Unequal Burden of Cancer: An Assessment of NIH Research and Programs from Ethnic Minorities and the Medically Underserved. Washington, DC: National Academy Press, 1999:1.
246. Wolff MS, Weston A. Breast cancer risk and environmental exposures. Environ Health Perspect. 1997;105(Suppl 4):891-896.
247. Millikan RC. Re: population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 2001;93:156-158.
248. Lin HJ, Han CY, Lin BK, Hardy S. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, blacks, Hispanics, and whites: Application to metabolic epidemiology. Am J Hum Genet. 1993;52:827-834.
249. Bell DA, Taylor JA, Butler MA, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis. 1993;14:1689-1692.
250. Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogenesis. 1995;16:1243-1245.
251. Weston A, Pan CF, Ksieski HB, et al. p53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:105-112.